Company
ValiRx PLC
LON:VAL
ValiRx is a drug development company, which focuses on the translation of scientific innovation into clinical candidates for cancer, related conditions and women’s health. The company's specialised business model connects science, finance and commerce to accelerate early-stage drug development. It identifies proprietary and novel drug candidates with the potential to improve patient lives, providing the expertise and investment required for optimised development and value creation.
310 stories · page 1 of 4
ValiRx signs service deal with TheoremRx; expects VAL201 sub-licence completion by end-Q1
ValiRx had previously expected to receive the first payments from the intended sub-licence with TheoremRx by the end of 2021
ValiRx inks new deal with Physiomics for cancer and coronavirus (COVID-19) programmes
“Enhancing the scientific understanding of our results using cutting edge technology ensures we maximise the value of the data we have collected," said VariRX chief executive Suzy Dilly.
ValiRx working on options to hold a meeting to vote on vital cash lifeline
The company adjourned the general meeting that was to be held on 25 March 2020 as a result of the COVID-19 situation
ValiRx says its treatment had a “clear impact on patients with prostate cancer”
The drug developer was at pains to stress this was only a very preliminary inference from the data measuring prostate-specific antigens and supported by tumour imagin
ValiRx updates on JV discussions and switches NOMAD
The company said it also expects to receive a tax credit shortly
Archive
Proactive news snapshot: Digitalbox, Seeing Machines, Alba Minerals Resources...
A glance at some of the day's highlights from the Proactive Investors newswire
ValiRx wins European patent protection for potential endometriosis treatment
VAL301 is in pre-clinical development as a non-invasive, effective treatment for endometriosis, which affects roughly 5-10% of women in their reproductive years
Archive
Rose Petroleum leaps as energy investor Jon Fitzpatrick picks up 5% stake in the company
A look at the day's major movers, including Xeros Technology Group, Redx Pharma, Bango, PageGroup, Hays, Jaywing and One Media iP Group
Archive
Proactive news snapshot: Redx Pharma, Feedback, Bango, SIMEC Atlantis …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
FTSE 100 closes lower as traders mull Fed testimony
The UK's premier share index finished down over five points lower at 7,530,
Archive
Proactive news snapshot: Argo Blockchain, ValiRx, Arc Minerals, Directa Plus ...
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Distil down the plug-hole after slump in revenues
A look at the day's major movers, including C&C, Global Ports, Carclo, ValiRx, IGas, Intelligent Ultrasound, Richland Resources and Bango
ValiRx readying itself for VAL301 clinical trials
ValiRx has brought in a contract research organisation that will help it take VAL301 into the clinic
Investments and investor services
FTSE 100 closes a shade lower as markets uninspired; US celebrates Independence Day holiday
The Footsie finished down nearly six points at 7,603
Archive
Proactive news snapshot: 88 Energy, Tekcapital, AFC Energy, SDX Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Kibo Energy the day's top riser as its moves to secure total ownership of the Bordersley project
A look at the day's major movers, including 88 Energy, Two Shields, Inland Homes, Avingtrans, Creightons, RM2 and RPS Group
ValiRx secures US patent for VAL201 cancer drug
ValiRx had already been granted worldwide rights for the use of VAL201 in prostate cancer, and US officials have now allowed claims for the use of the drug in the prevention and treatment of metastatic cancer, including prostate cancer
Archive
FTSE 100 still stuck in neutral; G20 meeting can't come soon enough
Bitcoin is up more than 10% but the shine has come off gold a bit
ValiRx agrees break fee as it terminates financing agreement
ValiRx will pay a break fee of £212,500 to European High Growth Opportunities SF after the pair agreed to terminate the financing deal
Archive
Proactive news snapshot: Shanta Gold, Ceres Power, Anglo Asian Mining …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
BCA Marketplace board minded to recommend 243p a share offer, if it is made
A look at the day's major movers, including Premier Technical, Evraz, Gunsynd, Dixons Carphone, Serabi Gold and EVR
ValiRx shares jump as firm cleared to increase clinical trial dosing
Investors were also told data from the trial is currently being collated for examination by independent experts, with Dr Mark Linch appointed as principal investigator
Investments and investor services
FTSE 100 closes higher as global markets buoyed by Fed's hint on rates
Carnival and Evra were the two big fallers among Footsie constituents
Investments and investor services
Maistro shares to become just a blurred memory
A look at the day's major movers, including Great Western Mining, Majestic Wine, Ascent, Ferguson and Just Group
Archive
Proactive news snapshot: Tekcapital, Quadrise Fuels International, Sareum Holdings …
A glance at some of the day's highlights from the Proactive Investors newswire
ValiRX raises funds to meet immediate working capital needs and develop drugs
ValiRX expects to pay European High Growth Opportunities Securitisation Fund up to £150,000 to terminate a subscription agreement.
Archive
Scapa boss not scarpering after all
A look at the day's major movers, including Helical, Ocado, Thomas Cook, Scapa, Dods Group, Rockfire Resources and Avesoro Resources
Archive
Proactive news snapshot: AfriTin Mining, Union Jack Oil, Eurasia Mining …
A glance at some of the day's highlights from the Proactive Investors newswire
ValiRx monitors working capital position amid talks to end subscription agreement with investor
ValiRX said it expects to announce the outcome of talks with European High Growth “shortly” and no longer intends to enter into further arrangements with the investor.
Investments and investor services
FTSE 100 closes higher as trade tensions ease
The UK's index of leading shares finished the first day of the trading week around 46 points higher at 7,378
Archive
Proactive news snapshot: Hemogenyx Pharmaceuticals, Bacanora Lithium, Arc Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Go-Ahead tracks up as it makes interim CFO permanent
A look at some of the biggest risers and fallers in London on Wednesday
Investments and investor services
FTSE 100 closes near flat as US ADP jobs report shakes confidence
The UK blue-chip share index finished up around four points at 7,218
Archive
Proactive news snapshot: NetScientific , Metal Tiger, ANGLE …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: Stobart Group, IQ-AI, Alba Mineral Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Netcall among Wednesday’s strugglers as its by NHS purchasing delays
Here's Wednesday's look at the major stock market movers
ValiRx outlines next step for prostate cancer drug
VAL201 has been shown to be safe and well tolerated during phase I/II trials and, crucially, there was “primary evidence” of the drug’s activity in patients
Archive
Proactive news snapshot: Berkeley Energia, Integumen, Highlands Natural Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Tertiary Minerals higher after announcing a new project acquisition in Nevada
A look at the day's major movers, including Pressure Technologies. Clontarf Technologies, Oxford Biomedica, Trafalgar Property, Yü, Proton Power and Frontier IP
ValiRx in talks to terminate subscription agreement and enter into a new convertible bond facility
The firm said its working capital position is dependent on new funds being made available to it and anticipates that the investor will provide it with additional funds under the new facility
Archive
FTSE 100 closes below its opening benchmark as trade war concerns cloud market sentiment
The UK blue-chip index ended 7.78 points lower at 7,265.98, just off the day's worst level of 7,263.80 after a topsy-turvey session which saw it hit a session high of 7,314.85 early on
Archive
Informa strikes TMT swap deal with IHS Markit
A look at some of the top risers and fallers on the London Stock Exchange on Wednesday, including 21st Century Technology, Thruvision, Hargreaves Services, Management Resource Solutions, SafeCharge International, IG Group, Pets at Home, and
Archive
Proactive news snapshot: Sound Energy, Bushveld Minerals, Motif Bio, IXICO …
A glance at some of the day's highlights from the Proactive Investors newswire
ValiRx updates on second round of funding discussions
The company has provided some detail on a potential second financing round
Archive
FTSE 100 closes slightly ahead but Wall Street shares slide
The Footsie closed out at 7,334 - up around five points, while mid-cap index was firmly lower- down 129 points at 19,307
Archive
Gresham shoots higher as contract wins make for “excellent start” to the year
A look at some of the biggest risers and fallers in London on Thursday
Archive
Proactive news snapshot: Haydale Graphene, Echo Energy, ValiRx, Personal Group …
A glance at some of the day's highlights from the Proactive Investors newswire
ValiRx makes acquisition and inks joint-venture deal
It has bought the assets of a Finnish biotech and set out the outline for a collaboration with a firm that offers specialist financing
ValiRx secures cash to fund VAL201 trial through to completion
In total, European High Growth Opportunities Securitisation Fund has agreed to make at least £7.3mln available to ValiRx bosses
Investments and investor services
Exillon Energy plunges after it calls in advisors to go over its accounts with a fine-toothed comb
A look at the day's major movers, including Bidstack, EU Supply, ReNeuron, Inspirit Energy, Prospex, Ferrexpo and Hastings Group
Archive
Proactive news snapshot: ReNeuron, Union Jack Oil, ANGLE, ECR Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
ValiRx primed for a pivotal year
Proactive takes a closer look at an innovative drugs company that has largely flown under the radar
Investments and investor services
Carnival sinks as it lowers full-year guidance
A look at the day's major movers, including Quartix, LiDCO, Convatec, PPHE, Boku and Coral Products
Archive
Proactive news snapshot: ValiRx, Erris Resources, Personal Group, S&U …
A glance at some of the day's highlights from the Proactive Investors newswire
Valirx says letters of intent signed to fund final stage trial of lung cancer drug
One European and one US group have the signed letters of intent for funding
Investments and investor services
WH Ireland claws back some recent losses as shareholders OK fund-raising
A look at the day's major movers, including Cadence Minerals, FW Thorpe, IG Group, LPA, Integrated Diagnostics, Wynnstay and Clear Leisure
Archive
Proactive news snapshot: ValiRx, LoopUp Group, Kibo Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
ValiRx boss “delighted” with progress of cancer drug VAL201 and VAL301 for endometriosis
VAL201 is coming towards the end of a Phase I/II study, while VAL301 is in late pre-clinical development
ValiRx raises £0.5mln in share placing to further expand scope of clinical trial for its prostate cancer treatment
The AIM-listed clinical stage biotechnology said its company broker, Novum Securities issued 83,333,333 new ordinary shares at a price of 0.6p each with new and existing investors
Archive
Proactive news snapshot: Faron Pharmaceuticals, Sunrise Resources, Tertiary Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: BigDish, ValiRx, Oriole Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Sylvania Platinum fails to flatten 'em - the sceptics, that is - with its production update
A look at the day's major movers, including Cambridge Cognition, SRT Marine, Redhall, FireAngel, Challenger Acquisitions, Alexander Mining and Blue Star Capital
ValiRx surges as it secures two new patents for VAL301 in Russia and China
The patents protect VAL301 as a treatment for endometriosis and prostate enlargement in two of the world’s most populous countries
Archive
Proactive news snapshot: Stobart Group, Berkeley Energia, ANGLE …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Lighthouse Group succumbs to profit taking
A look at the day's major movers, including Bidstack, NAHL, Flybe, Stobart Group and AO World
ValiRX confirms online publication of peer-reviewed article
VAL401 is a new formulation of the antipsychotic drug risperidone
Investments and investor services
FTSE 100 closes in red but nudges higher on the week; housebuilders gain on day
The UK blue-chip benchmark closed down around 24 points at 6,918, while FTSE 250 added nearly 107 points on the day
New long-term NHS plan bodes well for ValiRx
The ten-year plan, set out on Monday, includes a greater focus on earlier detection of cancers and personalised medicines, both of which ValiRx specialises in
Archive
Proactive news snapshot: Remote Monitored Systems, OptiBiotix Health, Columbus Energy Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: ValiRx, Avation, Sativa Investments …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Urals Energy tumbles again as war of words with Sergey Kononov intensifies
A look at the day's major movers, including redT, Rockfire, Oilex, SPDI and Orosur Mining
ValiRx hails publication of first peer-reviewed article on cancer treatment; raises £500k
The publication is intended to be the first in a series of results-based reports on VAL401, an antipsychotic drug that has been re-purposed for use in oncology
Archive
Proactive news snapshot: Avacta, ValiRx, Minds + Machines Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Pressure Technologies steps on the gas after agreeing to sell its alternative energy division
A look at the day's major movers, including Local Shopping REIT, Just Group, Photo-Me, Lb-Shell, Avacta and ValiRx
ValiRx’s VAL201 records “statistically significant” response in clinical trial
Participants in the trial treated with VAL201 displayed a “statistically significant correlation” for reductions over time in testosterone and prostate-specific antigen (PSA), commonly used markers for disease progression in prostate cancer
Investments and investor services
FTSE 100 closes lower as UK Prime Minister pulls plug on key Brexit vote
The UK premier index finished down around 56 points at 6,721 on Monday
Archive
Crest Nicholson shares fall on profit warning while Accesso advances on Groupon deal
A look at some winning and losing shares in the UK equity market on Wednesday
Archive
Proactive news snapshot: PowerHouse Energy, Ariana Resources, ValiRx …
A glance at some of the day's highlights from the Proactive Investors newswire
ValiRx enters final stages of phase I/II trial of its VAL201 prostate cancer drug
All of the current patients have received the escalated dose, meaning VAL201 is now on the home stretch of the early-stage study
FTSE 100 closes in the red as May set to address EU27
The FTSE 100 falls 35 points to 7,025, while Dow falls more than 300 points
Results from ValiRx’s phase II study of VAL401 anti-cancer compound to be published on ClinicalTrials.gov
The results’ publication onto ClinicalTrials.gov gives them further validation
Archive
Proactive news snapshot: ECR Minerals, Corero Network Security, Learning Technologies, Next Fifteen Communications …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A good day for most oil companies but not Amerisur or Hardy Oil and Gas
A look at the day's major movers, featuring Hardy Oil & Gas, Amerisur Resources, ECR, CMC, Low & Bonar, Corero Network Security and Learning Technologies Group
ValiRx hopes to expedite partner discussions with peer review of lung cancer treatment
VAL401 is ValiRx’s most advanced compound, with earlier trial results suggesting it can improve quality of life and chances of survival of lung cancer patients
ValiRx has raised £1.15mln via a share placing to accelerate its clinical and pre-clinical portfolio
The AIM-listed firm said it issued 76,666,666 new ordinary shares at a price of 1.50p each in the placing undertaken by the company's broker, Novum Securities
Archive
Proactive news snapshot: Sirius Minerals, Cradle Arc, Pan African Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Aquis Exchange unit inks three-year trading technology supply deal with crypto and security token exchange Archax
A look at some of the London market's biggest risers and fallers on Thursday
Archive
Proactive news snapshot: Maistro, Corero Network Security, Pan African Resources …
A glance at some of the day's highlights from the Proactive Investors newswire